Global Release of Hemp/Cannabis Genetic Classification and Testing Standards to Reshape Policy and Commerce

June 19, 2025 09:00 PM AEST | By EIN Presswire

Google News:

Global Release of Hemp/Cannabis Genetic Classification and Testing Standards to Reshape Policy and Commerce — Image source: EIN Presswire

Recent News

Yep AI Launches 24/7 AI Sales Agent on Shopify App Store

Spring 2025 Roundtable Recap: Advancing Beverage Environmental Sustain...

Patricia Corsi Named to Forbes World's Most Influential CMOs for...

Construction Adhesives Market Expansion New Developments and Trends by...

WASHINGTON, DC, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- A historic white paper co-authored by VpH and the Original Breeders League (OBL) titled “Hemp/Cannabis Testing Standard and Genetic Classification: A Framework for Innovation, Regulation, and Economic Growth” is released and now globally available.

This groundbreaking document provides a unified scientific foundation to support regulatory compliance, enhance therapeutic applications, and accelerate investment in the hemp and cannabis sectors. With pressure mounting globally around THC restrictions and quality control gaps, this paper delivers an actionable roadmap rooted in standardized testing and genetic classification.

Strategic Implications:

The paper proposes a model for governments, businesses, researchers, and health organizations to align on definitions, compliance, and IP protections—paving the way for scalable trade, improved patient outcomes, and global leadership in cannabinoid science.

VpH, a subsidiary of Vyripharm Enterprises Inc., partnered with OBL, a global steward of genetic integrity, to deliver this timely publication. Together, they address inconsistencies in labeling, lack of reproducibility in research, and mounting regulatory ambiguity.

Stakeholders across the value chain—from cultivators to policymakers—are encouraged to read the white paper and adopt its framework for real-time implementation.

The white paper is now available and can be downloaded directly from the Original Breeders League (https://www.oblintl.com/) or VpH (http://www.vyripharmbio.com) websites. Click the link.

Dr. Elias Jackson
VpH, a Subsidiary of Vyripharm Enterprises Inc.
email us here
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.